{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:00:30Z","timestamp":1781460030902,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Mycology Case Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.mmcr.2026.100782","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:52:43Z","timestamp":1773474763000},"page":"100782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A breakthrough invasive Aspergillus granulosus infection following azole antifungal therapy in a patient with primary myelofibrosis: case report"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4644-1299","authenticated-orcid":false,"given":"Watchapon","family":"Jaroensawang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piriyaporn","family":"Chongtrakool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4582-4914","authenticated-orcid":false,"given":"Methee","family":"Chayakulkeeree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4680-156X","authenticated-orcid":false,"given":"Anupop","family":"Jitmuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mmcr.2026.100782_bib1","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.mmcr.2026.100782_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J. Infect."},{"key":"10.1016\/j.mmcr.2026.100782_bib3","article-title":"Distribution of Aspergillus species and risk factors for aspergillosis in mainland China: a systematic review","volume":"11","author":"Khan","year":"2024","journal-title":"Ther. Adv. Infect. Dis."},{"issue":"2","key":"10.1016\/j.mmcr.2026.100782_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/jof6020084","article-title":"Clinical relevance and characteristics of Aspergillus calidoustus and other Aspergillus species of section Usti","volume":"6","author":"Glampedakis","year":"2020","journal-title":"J. Fungi"},{"issue":"2","key":"10.1016\/j.mmcr.2026.100782_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/jcm.33.2.471-473.1995","article-title":"First reported case of Aspergillus granulosus infection in a cardiac transplant patient","volume":"33","author":"Fakih","year":"1995","journal-title":"J. Clin. Microbiol."},{"issue":"10","key":"10.1016\/j.mmcr.2026.100782_bib6","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1128\/JCM.00588-09","article-title":"Cerebral aspergillosis caused by Aspergillus granulosus","volume":"47","author":"Sutton","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mmcr.2026.100782_bib7","article-title":"Aspergillus granulosus femoral osteomyelitis in a cardiac transplant patient: first reported case and literature review","volume":"11","author":"Giacinta","year":"2024","journal-title":"Ther. Adv. Infect. Dis."},{"issue":"17","key":"10.1016\/j.mmcr.2026.100782_bib8","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.3390\/jcm14176328","article-title":"Cytokine landscapes, immune dysregulation, and treatment perspectives in Philadelphia-negative myeloproliferative neoplasms: a narrative review","volume":"14","author":"Todor","year":"2025","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.mmcr.2026.100782_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/16078454.2021.1945237","article-title":"Expression profile analysis reveals hub genes that are associated with immune system dysregulation in primary myelofibrosis","volume":"26","author":"Ma","year":"2021","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.mmcr.2026.100782_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ajh.24976","article-title":"Ruxolitinib-associated infections: a systematic review and meta-analysis","volume":"93","author":"Lussana","year":"2017","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.mmcr.2026.100782_bib11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"Defining breakthrough invasive fungal infection: position paper of the Mycoses Study Group Education and Research Consortium and the European Confederation of Medical Mycology","volume":"62","author":"Cornely","year":"2019","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.mmcr.2026.100782_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jinf.2023.05.005","article-title":"Breakthrough invasive fungal infection among patients with haematologic malignancies: a national, prospective, and multicentre study","volume":"87","author":"Puerta-Alcalde","year":"2023","journal-title":"J. Infect."},{"issue":"2","key":"10.1016\/j.mmcr.2026.100782_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/jof11020160","article-title":"Outcome analysis of breakthrough invasive aspergillosis on anti-mold azole prophylaxis and treatment: 30-year experience in hematologic malignancy patients","volume":"11","author":"Dagher","year":"2025","journal-title":"J. Fungi"},{"key":"10.1016\/j.mmcr.2026.100782_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12281-023-00459-z","article-title":"Invasive aspergillosis and the impact of azole-resistance","volume":"17","author":"Bosetti","year":"2023","journal-title":"Curr. Fungal. Infect. Rep."},{"issue":"8","key":"10.1016\/j.mmcr.2026.100782_bib15","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.bbmt.2019.04.003","article-title":"Efficacy, toxicity, and infectious complications in ruxolitinib-treated patients with corticosteroid-refractory graft-versus-host disease after hematopoietic cell transplantation","volume":"25","author":"Abedin","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.mmcr.2026.100782_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/ciab1026","article-title":"Incidence of invasive fungal infections in patients initiating ibrutinib and other small molecule kinase inhibitors\u2014United States, July 2016\u2013June 2019","volume":"75","author":"Gold","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.mmcr.2026.100782_bib17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hon.2509","article-title":"Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: a multicenter study on 446 patients","volume":"36","author":"Polverelli","year":"2018","journal-title":"Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.mmcr.2026.100782_bib18","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.3390\/cancers13112611","article-title":"Untwining anti-tumor and immunosuppressive effects of JAK inhibitors\u2014A strategy for hematological malignancies?","volume":"13","author":"Klein","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mmcr.2026.100782_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.750346","article-title":"Immune dysregulation and infectious complications in MPN patients treated with JAK inhibitors","volume":"12","author":"Cattaneo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mmcr.2026.100782_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.simyco.2014.07.004","article-title":"Phylogeny, identification and nomenclature of the genus Aspergillus","volume":"78","author":"Samson","year":"2014","journal-title":"Stud. Mycol."},{"issue":"8","key":"10.1016\/j.mmcr.2026.100782_bib21","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/ciaa230","article-title":"Invasive aspergillosis due to Aspergillus section Usti: a multicenter retrospective study","volume":"72","author":"Glampedakis","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.mmcr.2026.100782_bib22","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3390\/pharmaceutics14102161","volume":"14","author":"Melhem","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.mmcr.2026.100782_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00280-24","article-title":"Comparative evaluation of Sensititre YeastOne and CLSI M38-Ed3 reference method for determining echinocandin minimum effective concentrations against Aspergillus isolates","volume":"12","author":"Potruch","year":"2024","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.mmcr.2026.100782_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/13693780902803040","article-title":"In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus","volume":"48","author":"Alastruey-Izquierdo","year":"2010","journal-title":"Med. Mycol."},{"key":"10.1016\/j.mmcr.2026.100782_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21\u201322","author":"Verweij","year":"2015","journal-title":"Drug Resist. Updates"}],"container-title":["Medical Mycology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211753926000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211753926000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:28:58Z","timestamp":1781458138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211753926000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":25,"alternative-id":["S2211753926000242"],"URL":"https:\/\/doi.org\/10.1016\/j.mmcr.2026.100782","relation":{},"ISSN":["2211-7539"],"issn-type":[{"value":"2211-7539","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A breakthrough invasive Aspergillus granulosus infection following azole antifungal therapy in a patient with primary myelofibrosis: case report","name":"articletitle","label":"Article Title"},{"value":"Medical Mycology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mmcr.2026.100782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.","name":"copyright","label":"Copyright"}],"article-number":"100782"}}